Search Results - "risk assessment"
Suggested Topics within your search.
Suggested Topics within your search.
- Risk Assessment 11
- genetics 5
- methods 5
- Genetic aspects 4
- Cancer 3
- Drugs 3
- prevention & control 3
- Disease susceptibility 2
- Drug Development 2
- Drug Evaluation, Preclinical 2
- Epigenesis, Genetic 2
- Gene-Environment Interaction 2
- Genetic Predisposition to Disease 2
- Molecular Epidemiology 2
- Molecular epidemiology 2
- Risk 2
- Risk Factors 2
- Safety measures 2
- Testing 2
- etiology 2
- standards 2
- statistics & numerical data 2
- Accidental Falls 1
- Adverse Drug Reaction Reporting Systems 1
- Air Pollution 1
- Asbestos 1
- Autoimmune Diseases 1
- Biostatistics 1
- Breast 1
- Breast Neoplasms 1
-
1
DNA methylation as a tumor marker implications for diagnosis, early detection and risk assessment /
Published 2010Get full text
Series
Electronic Video -
2
Cancer risk stratification the role of polygenic risk scores /
Published 2021Subjects: Get full text
Series
Electronic Video -
3
-
4
The risks and benefits of gene drive technology
Published 2019Subjects: Get full text
Series
Electronic Video -
5
Overview of nonclinical safety assessment
Published 2020Subjects: Get full text
Series
Electronic Video -
6
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine /
Published 2016Subjects: Get full text
Series
Electronic Video -
7
Toxicology of the developing immune system
Published 2012Subjects: Get full text
Series
Electronic Video -
8
Patient falls protecting patients and preventing injury /
Published 2019Subjects: Get full text
Series
Electronic Video -
9
PTEN Hamartoma-Tumour Syndrome a model for the practice of clinical cancer genetics /
Published 2014Subjects: Get full text
Series
Electronic Video -
10
A structured approach for pharmaceutical pre-marketing safety surveillance
Published 2021Subjects: Get full text
Electronic Video -
11
-
12
Molecular epidemiology of lung cancer
Published 2022Subjects: Get full text
Series
Electronic Video -
13
Ethical issues in molecular epidemiology and studies of gene-environment interactions
Published 2007Table of Contents: “…Contents: An experiment in science policy: the ethical, legal and social implications (ELSI) program -- Environmental response genes -- Applying genetic techniques in risk assessment: toxicogenomics -- Ethical issues in the application of genomic technologies in public health -- Misconceptions about genetic information -- Potential misapplications of genomic information or technologies -- Discrimination on the basis of genetic information -- Problems in assigning responsibility for poor health based upon genetic information -- The scope of future research with biological materials: ethical considerations.…”
Get full text
Series
Electronic Video -
14
Cardiovascular risk factors
Published 2008Table of Contents: “…Contents: Cardiovascular disease burden -- Atherosclerosis as a cause of CVD -- Non-modifiable and modifiable risk factors for CVD -- Dyslipidemia and CVD risk -- Apoproteins as CVD risk predictors -- Quality of lipoprotein particles as an important indicator of lipids associated risk -- Smoking as a CVD risk factor -- Diabetes as a risk factor for CVD -- Metabolic syndrome and CVD risk -- Risk assessment tools -- Atherosclerosis imaging techniques and risk assessment.…”
Get full text
Series
Electronic Video -
15
Epigenetically mediated gene silencing a companion to genetic alterations in driving tumorigenesis /
Published 2007Table of Contents: “…Contents: Introduction to epigenetic changes in cancer -- defining the process of promoter DNA hypermethylation as a constituent of a broad range of chromatin abnormalities in cancer -- defining the genes aberrantly silenced in cancer including approaches being used to screen the cancer genome for such genes -- defining what is known about the interaction of DNA methylation and chromatin modifications for initiating and maintaining gene silencing in cancer -- outlining the position of aberrant gene silencing in tumor progression and particularly highlighting the key role these changes may play for the earliest steps in tumorigenesis -- defining the potential for using DNA hypermethylated gene promoter sequences as molecular markers for cancer risk assessment, early diagnosis and prognosis -- discussing the possibilities for targeting reversal of gene silencing as a prevention and therapeutic strategy for cancer.…”
Get full text
Series
Electronic Video